Trulieve Cannabis (TCNNF) Gross Margin (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Gross Margin of 59.31% in Q1 2026, down 0.74% quarter-over-quarter from 59.75% in Q4 2025, and down 222.0% on a YoY basis from 48.62% in Q1 2025.
Trulieve Cannabis (TCNNF) Gross Margin (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Gross Margin history runs 7 years deep, the most recent figure standing at 59.31% for Q1 2026.
- In Q1 2026, Gross Margin fell 222.0% year-over-year to 59.31%; the TTM figure through Mar 2026 stood at 59.65% (down 146.0% YoY), while the FY2025 annual figure was 60.21%, down 12.0% from the prior year.
- Gross Margin was 59.31% for Q1 2026 at Trulieve Cannabis, down from 59.75% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 62.1% in Q4 2024 to a low of 50.26% in Q2 2023.
- Historically, Gross Margin has averaged 57.34% across 5 years, with a median of 58.43% in 2022.
- The sharpest annual moves came in 2022 and 2024: Gross Margin slumped 1300 bps in 2022, then soared 960 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 52.64% in 2022, then climbed by 2 bps to 53.61% in 2023, then increased by 16 bps to 62.1% in 2024, then slipped by 4 bps to 59.75% in 2025, then fell by 1 bps to 59.31% in 2026.
- The last three Gross Margin figures came in at 59.31% (Q1 2026), 59.75% (Q4 2025), and 58.94% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 59.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.31% |
| Dec 31, 2025 | 59.75% |
| Sep 30, 2025 | 58.94% |
| Jun 30, 2025 | 60.55% |
| Mar 31, 2025 | 61.53% |
| Dec 31, 2024 | 62.10% |
| Sep 30, 2024 | 60.95% |
| Jun 30, 2024 | 59.86% |
| Mar 31, 2024 | 58.40% |
| Dec 31, 2023 | 53.61% |
| Sep 30, 2023 | 51.94% |
| Jun 30, 2023 | 50.26% |
| Mar 31, 2023 | 52.66% |
| Dec 31, 2022 | 52.64% |
| Sep 30, 2022 | 57.12% |
| Jun 30, 2022 | 58.43% |
| Mar 31, 2022 | 56.79% |
| Dec 31, 2021 | 44.46% |
| Sep 30, 2021 | 68.70% |
| Jun 30, 2021 | 67.16% |